Preterm human milk contains a large pool of latent TGF-β, which can be activated by exogenous neuraminidase

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 304, Issue 12, 2013, Pages

  Namachivayam, Kopperuncholan ^a   Blanco, Cynthia L ^b   Frost, Brandy L ^a,c   Reeves, Aaron A ^b   Jagadeeswaran, Ramasamy ^a   Mohankumar, Krishnan ^a   Safarulla, Azif ^a   Mandal, Partha ^a   Garzon, Steven A ^a,d   Raj, J Usha ^a   Maheshwari, Akhil ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Breast milk; Inflammation; Necrotizing enterocolitis; Sialidase; Transforming growth factor

Indexed keywords

SIALIDASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; BREAST MILK; DELIVERY; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; EXPLANT; GESTATION PERIOD; HIGH RISK INFANT; HUMAN; INFANT; MOUSE; NECROTIZING ENTEROCOLITIS; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BREAST MILK; INFLAMMATION; NECROTIZING ENTEROCOLITIS; SIALIDASE; TRANSFORMING GROWTH FACTOR-Β;

ANIMALS; FEMALE; GENE EXPRESSION; HUMANS; LACTATION; MICE; MILK, HUMAN; NEURAMINIDASE; NF-KAPPA B; PREMATURE BIRTH; PROTEIN ISOFORMS; TERM BIRTH; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84879139730     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00039.2013     Document Type: Article

References (72)

1. Ambalavanan N, Nicola T, Li P, Bulger A, Murphy-Ullrich J, Oparil S, Chen YF. Role of matrix metalloproteinase-2 in newborn mouse lungs under hypoxic conditions. Pediatr Res 63: 26-32, 2008.
2. Ames MD. Gastric acidity in the first ten days of life of the prematurely born baby. Am J Dis Child 100: 252-256, 1960.
3. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGF activation. J Cell Sci 116: 217-224, 2003.
4. Ayoub IA, Yang TJ. The regulatory role of transforming growth factorin activation of milk mononuclear cells. Am J Reprod Immunol 38: 121-128, 1997.
5. Benjamin JT, Smith RJ, Halloran BA, Day TJ, Kelly DR, Prince LS. FGF-10 is decreased in bronchopulmonary dysplasia and suppressed by Toll-like receptor activation. Am J Physiol Lung Cell Mol Physiol 292: L550-L558, 2007.
6. Bishop CE, Vasquez MM, Petershack JE, Blanco CL. Pasteurized donor human milk for VLBW infants: the effect on necrotizing enterocolitis and related factors. J Neonatal Perinatal Med 3: 87-93, 2010.
7. Boralessa H, Modi N, Cockburn H, Malde R, Edwards M, Roberts I, Letsky E. RBC T activation and hemolysis in a neonatal intensive care population: implications for transfusion practice. Transfusion 42: 1428-1434, 2002.
8. Böttcher MF, Abrahamsson TR, Fredriksson M, Jakobsson T, Bjorksten B. Low breast milk TGF-β2 is induced by Lactobacillus reuteri supplementation and associates with reduced risk of sensitization during infancy. Pediatr Allergy Immunol 19: 497-504, 2008.
9. Böttcher MF, Jenmalm MC, Garofalo RP, Bjorksten B. Cytokines in breast milk from allergic and nonallergic mothers. Pediatr Res 47: 157-162, 2000.
10. Carlson CM, Turpin EA, Moser LA, O'Brien KB, Cline TD, Jones JC, Tumpey TM, Katz JM, Kelley LA, Gauldie J, Schultz-Cherry S. Transforming growth factor-β: activation by neuraminidase and role in highly pathogenic H5N1 influenza pathogenesis. PLoS Pathogens 6: e1001136, 2010.
11. Chockalingam A, Paape MJ, Bannerman DD. Increased milk levels of transforming growth factor-α, β1, and 2 during Escherichia coli-induced mastitis. J Dairy Sci 88: 1986-1993, 2005.
12. Claud EC, Savidge T, Walker WA. Modulation of human intestinal epithelial cell IL-8 secretion by human milk factors. Pediatr Res 53: 419-425, 2003.
13. Cochran JB, Panzarino VM, Maes LY, Tecklenburg FW. Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome and anemia. Pediatr Nephrol 19: 317-321, 2004.
14. Cox DA, Burk RR. Isolation and characterisation of milk growth factor, a transforming-growth-factor-β2-related polypeptide, from bovine milk. Eur J Biochem 197: 353-358, 1991.
15. Donnet-Hughes A, Duc N, Serrant P, Vidal K, Schiffrin EJ. Bioactive molecules in milk and their role in health and disease: the role of transforming growth factor-. Immunol Cell Biol 78: 74-79, 2000.
16. Filteau SM, Lietz G, Mulokozi G, Bilotta S, Henry CJ, Tomkins AM. Milk cytokines and subclinical breast inflammation in Tanzanian women: effects of dietary red palm oil or sunflower oil supplementation. Immunology 97: 595-600, 1999.
17. Franke WW, Heid HW, Grund C, Winter S, Freudenstein C, Schmid E, Jarasch ED, Keenan TW. Antibodies to the major insoluble milk fat globule membrane-associated protein: specific location in apical regions of lactating epithelial cells. J Cell Biol 89: 485-494, 1981.
18. Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL. A review of premature birth and subclinical infection. Am J Obstet Gynecol 166: 1515-1528, 1992.
19. Hawkes JS, Bryan DL, Gibson RA. Variations in transforming growth factorin human milk are not related to levels in plasma. Cytokine 17: 182-186, 2002.
20. 2 in human milk during the first three months postpartum. Pediatr Res 46: 194-199, 1999.
21. Hawkes JS, Bryan DL, Neumann MA, Makrides M, Gibson RA. Transforming growth factorin human milk does not change in response to modest intakes of docosahexaenoic acid. Lipids 36: 1179-1181, 2001.
22. Ishizaka S, Kimoto M, Tsujii T, Saito S. Antibody production system modulated by oral administration of human milk and TGF-β. Cell Immunol 159: 77-84, 1994.
23. Jenkins G. The role of proteases in transforming growth factoractivation. Int J Biochem Cell Biol 40: 1068-1078, 2008.
24. Kalliomaki M, Ouwehand A, Arvilommi H, Kero P, Isolauri E. Transforming growth factorin breast milk: a potential regulator of atopic disease at an early age. J Allergy Clin Immunol 104: 1251-1257, 1999.
25. Kim YK, Na KS, Shin KH, Jung HY, Choi SH, Kim JB. Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 31: 1044-1053, 2007.
26. Kondo N, Suda Y, Nakao A, Oh-Oka K, Suzuki K, Ishimaru K, Sato M, Tanaka T, Nagai A, Yamagata Z. Maternal psychosocial factors determining the concentrations of transforming growth factorin breast milk. Pediatr Allergy Immunol 22: 853-861, 2011.
27. Kurakata H, Oka M, Matsubara Y, Niwa T, Utsunomiya H, Fujishiro M, Miki K, Fukamachi H, Kubota S, Ichinose M. Developmentally regulated expression of matrix metalloproteinases during fetal rat colon morphogenesis. Dev Growth Differ 50: 41-48, 2008.
28. Kverka M, Burianova J, Lodinova-Zadnikova R, Kocourkova I, Cinova J, Tuckova L, Tlaskalova-Hogenova H. Cytokine profiling in human colostrum and milk by protein array. Clin Chem 53: 955-962, 2007.
29. Laiho K, Lampi AM, Hamalainen M, Moilanen E, Piironen V, Arvola T, Syrjanen S, Isolauri E. Breast milk fatty acids, eicosanoids, and cytokines in mothers with and without allergic disease. Pediatr Res 53: 642-647, 2003.
30. Lebman DA, Edmiston JS. The role of TGF-β in growth, differentiation, and maturation of B lymphocytes. Microbes Infect Institut Pasteur 1: 1297-1304, 1999.
31. Letterio JJ, Geiser AG, Kulkarni AB, Roche NS, Sporn MB, Roberts AB. Maternal rescue of transforming growth factor1 null mice. Science 264: 1936-1938, 1994.
32. + regulatory T cells and its 5-HT1a receptor in patients with major depression disorder. J Affect Disord 124: 68-75, 2010.
33. Lopez-Alonso M, Moya MJ, Cabo JA, Ribas J, del Carmen Macias M, Silny J, Sifrim D. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux. Pediatrics 118: e299-e308, 2006.
34. Maheshwari A, Kelly DR, Nicola T, Ambalavanan N, Jain SK, Murphy-Ullrich J, Athar M, Shimamura M, Bhandari V, Aprahamian C, Dimmitt RA, Serra R, Ohls RK. TGF-β2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine. Gastroenterology 140: 242-253, 2011.
35. Maheshwari A, Voitenok NN, Akalovich S, Shaik SS, Randolph DA, Sims B, Patel RP, Killingsworth CR, Fallon MB, Ohls RK. Developmental changes in circulating IL-8/CXCL8 isoforms in neonates. Cytokine 46: 12-16, 2009.
36. Marek A, Zagierski M, Liberek A, Aleksandrowicz E, Korzon M, Krzykowski G, Kaminska B, Szlagatys-Sidorkiewicz A. TGF-β1, IL-10 and IL-4 in colostrum of allergic and nonallergic mothers. Acta Biochim Pol 56: 411-414, 2009.
37. Massague J, Cheifetz S, Laiho M, Ralph DA, Weis FM, Zentella A. Transforming growth factor-β. Cancer Surv 12: 81-103, 1992.
38. McPherson RJ, Wagner CL. The effect of pasteurization on transforming growth factor-β and transforming growth factor-β2 concentrations in human milk. Adv Exp Med Biol 501: 559-566, 2001.
39. Miyazono K, Heldin CH. Role for carbohydrate structures in TGF-β1 latency. Nature 338: 158-160, 1989.
40. MohanKumar K, Kaza N, Jagadeeswaran R, Garzon SA, Bansal A, Kurundkar AR, Namachivayam K, Remon JI, Bandepalli CR, Feng X, Weitkamp JH, Maheshwari A. Gut mucosal injury in neonates is marked by macrophage infiltration in contrast to pleomorphic infiltrates in adult: evidence from an animal model. Am J Physiol Gastrointest Liver Physiol 303: G93-G102, 2012.
41. Monti E, Bonten E, D'Azzo A, Bresciani R, Venerando B, Borsani G, Schauer R, Tettamanti G. Sialidases in vertebrates: a family of enzymes tailored for several cell functions. Adv Carbohydr Chem Biochem 64: 403-479, 2010.
42. Moore HM, Kelly AB, Jewell SD, McShane LM, Clark DP, Greenspan R, Hayes DF, Hainaut P, Kim P, Mansfield EA, Potapova O, Riegman P, Rubinstein Y, Seijo E, Somiari S, Watson P, Weier HU, Zhu C, Vaught J. Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathol 119: 92-101, 2011.
43. Munger JS, Harpel JG, Gleizes PE, Mazzieri R, Nunes I, Rifkin DB. Latent transforming growth factor-β: structural features and mechanisms of activation. Kidney Int 51: 1376-1382, 1997.
44. Munger JS, Sheppard D. Cross talk among TGF-β signaling pathways, integrins, and the extracellular matrix. Cold Spring Harbor Perspect Biol 3: a005017, 2011.
45. Nakamura Y, Miyata M, Ando T, Shimokawa N, Ohnuma Y, Katoh R, Ogawa H, Okumura K, Nakao A. The latent form of transforming growth factor-β administered orally is activated by gastric acid in mice. J Nutr 139: 1463-1468, 2009.
46. Namachivayam K, Blanco CL, Mohankumar K, Jagadeeswaran R, Vasquez M, McGill-Vargas L, Garzon SA, Jain SK, Gill RK, Freitag NE, Weitkamp JH, Seidner SR, Maheshwari A. Smad7 inhibits autocrine expression of TGF-β2 in intestinal epithelial cells in baboon necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 304: G167-G180, 2013.
47. Oddy WH, McMahon RJ. Milk-derived or recombinant transforming growth factor-β has effects on immunological outcomes: a review of evidence from animal experimental studies. Clin Exp Allergy 41: 783-793, 2011.
48. Ogawa J, Sasahara A, Yoshida T, Sira MM, Futatani T, Kanegane H, Miyawaki T. Role of transforming growth factor-β in breast milk for initiation of IgA production in newborn infants. Early Hum Dev 77: 67-75, 2004.
49. Ozawa T, Miyata M, Nishimura M, Ando T, Ouyang Y, Ohba T, Shimokawa N, Ohnuma Y, Katoh R, Ogawa H, Nakao A. Transforming growth factor-β activity in commercially available pasteurized cow milk provides protection against inflammation in mice. J Nutr 139: 69-75, 2009.
50. Pakkanen R. Determination of transforming growth factor-β2 (TGF-β2) in bovine colostrum samples. J Immunoassay 19: 23-37, 1998.
51. Penttila IA. Milk-derived transforming growth factor-β and the infant immune response. J Pediatr 156: S21-S25, 2010.
52. Penttila IA, van Spriel AB, Zhang MF, Xian CJ, Steeb CB, Cummins AG, Zola H, Read LC. Transforming growth factor-β levels in maternal milk and expression in postnatal rat duodenum and ileum. Pediatr Res 44: 524-531, 1998.
53. Prescott SL, Wickens K, Westcott L, Jung W, Currie H, Black PN, Stanley TV, Mitchell EA, Fitzharris P, Siebers R, Wu L, Crane J. Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-γ and breast milk transforming growth factor-γ and immunoglobin A detection. Clin Exp Allergy 38: 1606-1614, 2008.
54. Quigley MA, Henderson G, Anthony MY, McGuire W. Formula milk versus donor breast milk for feeding preterm or low birth weight infants (Online). Cochrane Database Syst Rev Oct 17: CD002971, 2007.
55. Rautava S, Kalliomaki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 109: 119-121, 2002.
56. Rautava S, Lu L, Nanthakumar NN, Dubert-Ferrandon A, Walker WA. TGF-β2 induces maturation of immature human intestinal epithelial cells and inhibits inflammatory cytokine responses induced via the NF-βB pathway. J Pediatr Gastroenterol Nutr 54: 630-638, 2012.
57. Rautava S, Nanthakumar NN, Dubert-Ferrandon A, Lu L, Rautava J, Walker WA. Breast milk transforming growth factor-β2 specifically attenuates IL-1β-induced inflammatory responses in the immature human intestine via an Smad6- and ERK-dependent mechanism. Neonatology 99: 192-201, 2011.
58. Ribeiro SM, Poczatek M, Schultz-Cherry S, Villain M, Murphy-Ullrich JE. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-β. J Biol Chem 274: 13586-13593, 1999.
59. Rigotti E, Piacentini GL, Ress M, Pigozzi R, Boner AL, Peroni DG. Transforming growth factor-β and interleukin-10 in breast milk and development of atopic diseases in infants. Clin Exp Allergy 36: 614-618, 2006.
60. Rogers ML, Goddard C, Regester GO, Ballard FJ, Belford DA. Transforming growth factor-β in bovine milk: concentration, stability and molecular mass forms. J Endocrinol 151: 77-86, 1996.
61. Saarinen KM, Vaarala O, Klemetti P, Savilahti E. Transforming growth factor-β1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. J Allergy Clin Immunol 104: 1093-1098, 1999.
62. Saito S, Yoshida M, Ichijo M, Ishizaka S, Tsujii T. Transforming growth factor-β (TGF-β) in human milk. Clin Exp Immunol 94: 220-224, 1993.
63. Sangild PT, Mei J, Fowden AL, Xu RJ. The prenatal porcine intestine has low transforming growth factor-β ligand and receptor density and shows reduced trophic response to enteral diets. Am J Physiol Regul Integr Comp Physiol 296: R1053-R1062, 2009.
64. Sha X, Yang L, Gentry LE. Identification and analysis of discrete functional domains in the pro region of pre-pro-transforming growth factor-β1. J Cell Biol 114: 827-839, 1991.
65. Shaik SS, Soltau TD, Chaturvedi G, Totapally B, Hagood JS, Andrews WW, Athar M, Voitenok NN, Killingsworth CR, Patel RP, Fallon MB, Maheshwari A. Low intensity shear stress increases endothelial ELR CXC chemokine production via a focal adhesion kinasep38β MAPK-NF-κB pathway. J Biol Chem 284: 5945-5955, 2009.
66. Srivastava MD, Srivastava A, Brouhard B, Saneto R, Groh-Wargo S, Kubit J. Cytokines in human milk. Res Commun Mol Pathol Pharmacol 93: 263-287, 1996.
67. Sullivan S, Schanler RJ, Kim JH, Patel AL, Trawoger R, Kiechl-Kohlendorfer U, Chan GM, Blanco CL, Abrams S, Cotten CM, Laroia N, Ehrenkranz RA, Dudell G, Cristofalo EA, Meier P, Lee ML, Rechtman DJ, Lucas A. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr 156: 562-567, 2010.
68. Tomicic S, Johansson G, Voor T, Bjorksten B, Bottcher MF, Jenmalm MC. Breast milk cytokine and IgA composition differ in Estonian and Swedish mothers-relationship to microbial pressure and infant allergy. Pediatr Res 68: 330-334, 2010.
69. Verhasselt V. Neonatal tolerance under breastfeeding influence: the presence of allergen and transforming growth factor-β in breast milk protects the progeny from allergic asthma. J Pediatr 156: S16-S20, 2010.
70. Wiederschain GY, Newburg DS. Glycoconjugate stability in human milk: glycosidase activities and sugar release. J Nutr Biochem 12: 559-564, 2001.
71. Xu R, Doan QC, Regester GO. Detection and characterisation of transforming growth factor-β in porcine colostrum. Biol Neonate 75: 59-64, 1999.
72. Zou Z, Sun PD. An improved recombinant mammalian cell expression system for human transforming growth factor-β2 and-β3 preparations. Protein Expr Purif 50: 9-17, 2006.